Cargando…

A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models

Detalles Bibliográficos
Autores principales:	Ramanujan, Saroja, Chan, Jason R., Friedrich, Christina M., Thalhauser, Craig J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617835/ https://www.ncbi.nlm.nih.gov/pubmed/30983158 http://dx.doi.org/10.1002/psp4.12409

Ejemplares similares

Quantitative Systems Pharmacology: A Case for Disease Models
por: Musante, CJ, et al.
Publicado: (2016)

Corrigendum: A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models
Publicado: (2020)

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
por: Kierzek, Andrzej M., et al.
Publicado: (2019)

Incorporating Placebo Response in Quantitative Systems Pharmacology Models
por: Wang, Evan B., et al.
Publicado: (2019)

Industrialization of Quantitative Systems Pharmacology
por: Topp, Brian, et al.
Publicado: (2019)

Quantitative systems pharmacology model‐based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3‐kinase inhibitors
por: Gadkar, Kapil, et al.
Publicado: (2021)

A quantitative systems pharmacology approach to support mRNA vaccine development and optimization
por: Selvaggio, Gianluca, et al.
Publicado: (2021)

NIH Support for the Emergence of Quantitative and Systems Pharmacology
por: Rogers, M, et al.
Publicado: (2013)

Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach
por: Gadkar, Kapil, et al.
Publicado: (2016)

Quantitative Systems Pharmacology and Empirical Models: Friends or Foes?
por: Benson, Neil
Publicado: (2019)

Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
por: Zineh, Issam
Publicado: (2019)

Learn–confirm in model‐informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
por: Franssen, Linnea C., et al.
Publicado: (2022)

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue
por: Stroh, M, et al.
Publicado: (2015)

A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
por: Ermakov, Sergey, et al.
Publicado: (2019)

Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
por: Schmidt, Stephan, et al.
Publicado: (2019)

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation
por: Ribba, B, et al.
Publicado: (2017)

A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability
por: Sher, Anna, et al.
Publicado: (2022)

A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development
por: Bai, Jane P. F., et al.
Publicado: (2020)

Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates
por: Ramakrishnan, Vidya, et al.
Publicado: (2022)

Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses
por: Gieschke, Ronald, et al.
Publicado: (2022)

Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
por: Giorgi, Mario, et al.
Publicado: (2021)

Considerations for Adapting Pre-existing Mechanistic Quantitative Systems Pharmacology Models for New Research Contexts
por: Weis, Michael, et al.
Publicado: (2019)

FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
por: Peterson, MC, et al.
Publicado: (2015)

Potential Issues With Virtual Populations When Applied to Nonlinear Quantitative Systems Pharmacology Models
por: Duffull, Stephen, et al.
Publicado: (2020)

Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID‐19
por: Hartman, Dan, et al.
Publicado: (2020)

Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges
por: Musuamba, Flora T., et al.
Publicado: (2020)

Model‐informed target identification and validation through combining quantitative systems pharmacology with network‐based analysis
por: Chelliah, Vijayalakshmi, et al.
Publicado: (2022)

The Context-Dependence of Mutations: A Linkage of Formalisms
por: Poelwijk, Frank J., et al.
Publicado: (2016)

GPS for QSP: A Summary of the ACoP6 Symposium on Quantitative Systems Pharmacology and a Stage for Near‐Term Efforts in the Field
por: Musante, CJ, et al.
Publicado: (2016)

Graphical Modeling Meets Systems Pharmacology
por: Lombardo, Rosario, et al.
Publicado: (2017)

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?
por: Shakhnovich, Valentina, et al.
Publicado: (2019)

Parthenolide: a novel pharmacological approach to promote nerve regeneration
por: Diekmann, Heike, et al.
Publicado: (2016)

Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma
por: Fresnais, Margaux, et al.
Publicado: (2021)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

AI-Enabled Wearable and Flexible Electronics for Assessing Full Personal Exposures
por: Shan, Guangcun, et al.
Publicado: (2020)

In defense of quantitative metrics in researcher assessments
por: Ioannidis, John P. A., et al.
Publicado: (2023)

Open Systems Pharmacology Community—An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences
por: Lippert, Jörg, et al.
Publicado: (2019)

Response to “Quantitative Clinical Pharmacology INPUT to SARS‐CoV‐2 Therapeutics Should be Based on Robust Data”
por: Garcia‐Cremades, Maria, et al.
Publicado: (2020)

Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology
por: Vicini, Paolo, et al.
Publicado: (2019)

Approach to the pharmacological management of chronic pain in patients with an alcohol use disorder
por: Murphy, Laura, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v6aotguf7cv91qkn2anjuiltht